GOVX GeoVax Labs Inc

Price (delayed)

$0.378

Market cap

$2.79M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$9.59

Enterprise value

-$34,707

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 5

GeoVax Labs, Inc. (GeoVax) is a biotechnology company that prevent and fight human immunodeficiency virus (HIV). The Company's vaccines prevent HIV infection and to serve as a treatment for individuals ...

Highlights
The EPS has soared by 81% year-on-year and by 45% since the previous quarter
The debt is down by 18% since the previous quarter
The quick ratio has soared by 111% from the previous quarter but it has contracted by 19% YoY
The equity has declined by 38% year-on-year

Key stats

What are the main financial stats of GOVX

GOVX stock price

How has the GeoVax Labs stock price performed over time
Intraday
4.05%
1 week
-6.71%
1 month
-41.45%
1 year
-97.67%
YTD
-91.17%
QTD
-70.24%

Financial performance

How have GeoVax Labs's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$20.53M
Net income
-$20.43M
Gross margin
N/A
Net margin
N/A
The operating income has grown by 34% YoY and by 8% from the previous quarter
GeoVax Labs's net income has increased by 18% YoY and by 4.4% from the previous quarter

Price vs fundamentals

How does GOVX's price correlate with its fundamentals

Growth

What is GeoVax Labs's growth rate over time

Valuation

What is GeoVax Labs stock price valuation
P/E
N/A
P/B
1.12
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has soared by 81% year-on-year and by 45% since the previous quarter
The P/B is 83% less than the 5-year quarterly average of 6.4 and 68% less than the last 4 quarters average of 3.4
The equity has declined by 38% year-on-year

Efficiency

How efficient is GeoVax Labs business performance
The return on equity has dropped by 82% year-on-year and by 4.8% since the previous quarter
GOVX's return on invested capital has dropped by 56% since the previous quarter
The ROA has declined by 41% year-on-year

Dividends

What is GOVX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for GOVX.

Financial health

How did GeoVax Labs financials performed over time
GOVX's total assets is 61% more than its total liabilities
The quick ratio has soared by 111% from the previous quarter but it has contracted by 19% YoY
GOVX's total assets has soared by 56% from the previous quarter but it is down by 13% YoY
The debt is 82% smaller than the equity
The debt to equity has dropped by 78% since the previous quarter
The equity has declined by 38% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.